QuidelOrtho (QDEL) Capital Expenditures Growth (1y) (2023 - 2026)
QuidelOrtho (QDEL) Capital Expenditures Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -11.95% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 106.98% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -47.73% |
| 10 | QuidelOrtho | 1.15 Bn | 1.01 Bn | - | -39.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -39.50% |
| Dec 28, 2025 | -4.03% |
| Sep 28, 2025 | 5.81% |
| Jun 29, 2025 | 6.23% |
| Mar 30, 2025 | -14.98% |
| Dec 29, 2024 | -2.88% |
| Sep 29, 2024 | 7.14% |
| Jun 30, 2024 | -31.19% |
| Mar 31, 2024 | 0.15% |
| Dec 31, 2023 | 140.67% |
| Apr 2, 2023 | 193.33% |